Austell Laboratories has launched Colbanâ˘ a chewable probiotic tablet to help the human body fight the common cold.
Online PR News – 26-August-2011 – – According to the World Health Organization (WHO), probiotics have a beneficial effect on human health. Probiotics are organisms that live in the intestinal tract, which makes up 70% of the immune system. The two living bacterium strains in Colbanâ˘ are Lactobacillus paracasei 8700:2 and Lactobacillus plantarum Heal 9, both of which are known to support the immune system.
In a series of double-blind, placebo-controlled studies, cold sufferers who took probiotics showed an easing of their symptoms within 6.2 days when compared to 8.6 days for those that had taken the placebo. While 67% of those candidates on the placebo acquired the common cold, only 55% of those taking probiotics were similarly afflicted.
In every test, those taking probiotics had less symptoms, of lesser severity that passed sooner. âFrom these studies, we can deduce that Colban is the first proven probiotic that is effective at reducing the intensity and duration of the common cold,â says George Prinsloo at Austell Laboratories. âAdd this to its excellent safety and tolerability, and the ease of taking only one chewable tablet once a day, and you have a solution that significantly eases this commonest of ailments.â
In addition to being effective during episodes of cold, Colban can be taken as a general immune system booster throughout the month. âFor those prone to colds, Colban has been shown to reduce the incidence of colds in the long term due to the immune support that the probiotic offersâ, says Prinsloo. The elderly, those with asthma, emphysema, immune compromised individuals, those on chronic medication and children (who can chew) can all take Colban preventatively to improve general immunity.
Colban is a chewable, convex white tablet with speckles and is available in bottles of 30. For more information, contact George Prinsloo on firstname.lastname@example.org.